Inspire Veterinary Partners(IVPR)
$0.000.00 (0.00%)
IVPR
Inspire Veterinary Partners financials statements
$0.00
At close:0.00 (0.00%)
Want to see IVPR full AI Analyst Report?
Inspire Veterinary Partners (IVPR) Ratios
502 Followers
Inspire Veterinary Partners Ratios
IVPR's free cash flow for Q3 2025 was $-1.33M. For the 2025 fiscal year, IVPR's free cash flow was decreased by $-43.47K and operating cash flow was $-1.28M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 0.18 | 0.24 | 1.19 | 0.00 |
| Quick Ratio | 0.18 | 0.10 | 0.16 | 1.17 | 0.00 |
| Cash Ratio | 0.06 | 0.02 | 0.06 | 1.03 | 0.00 |
| Solvency Ratio | -0.68 | -0.59 | -0.17 | -0.17 | 0.00 |
| Operating Cash Flow Ratio | -1.22 | -0.50 | -0.37 | -0.50 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -1.74 | -1.16 | -0.49 | -0.67 | 0.00 |
| Net Current Asset Value | $ -16.61M | $ -21.23M | $ -23.58M | $ -4.81M | $ 21.97K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.81 | 0.85 | 1.17 | 1.06 | 0.00 |
| Debt-to-Equity Ratio | 10.48 | -23.37 | -4.60 | -7.70 | 0.00 |
| Debt-to-Capital Ratio | 0.91 | 1.04 | 1.28 | 1.15 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.84 | 1.06 | 1.42 | 1.20 | 0.00 |
| Financial Leverage Ratio | 12.93 | -27.64 | -3.93 | -7.28 | 1.00 |
| Debt Service Coverage Ratio | -1.07 | -1.86 | -0.42 | -0.62 | 0.00 |
| Interest Coverage Ratio | -2.91 | -2.83 | -2.47 | -5.38 | 0.00 |
| Debt to Market Cap | 0.54 | 7.27 | 0.03 | 0.01 | 0.00 |
| Interest Debt Per Share | 3.51 | 7829.92 | 224.09 | 61.66 | 0.00 |
| Net Debt to EBITDA | -1.67 | -1.68 | -7.97 | -4.74 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.84% | 21.31% | 25.88% | 32.53% | 0.00% |
| EBIT Margin | -67.30% | -73.49% | -35.76% | -41.66% | 0.00% |
| EBITDA Margin | -57.25% | -65.00% | -29.56% | -38.34% | 0.00% |
| Operating Profit Margin | -54.41% | -43.12% | -35.77% | -41.08% | 0.00% |
| Pretax Profit Margin | -85.97% | -88.71% | -50.25% | -49.30% | 0.00% |
| Net Profit Margin | -85.97% | -88.71% | -49.94% | -52.22% | 0.00% |
| Continuous Operations Profit Margin | -85.97% | -88.71% | -49.94% | -52.22% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 99.39% | 105.91% | 100.00% |
| EBT Per EBIT | 158.02% | 205.71% | 140.47% | 120.01% | 100.00% |
| Return on Assets (ROA) | -70.63% | -67.89% | -24.33% | -21.03% | -25.13% |
| Return on Equity (ROE) | -913.20% | 1876.65% | 95.65% | 153.16% | -25.13% |
| Return on Capital Employed (ROCE) | -75.25% | -50.61% | -27.20% | -24.21% | -25.13% |
| Return on Invested Capital (ROIC) | -50.34% | -40.78% | -18.93% | -19.04% | -25.13% |
| Return on Tangible Assets | -135.33% | -132.91% | -49.91% | -29.71% | -25.13% |
| Earnings Yield | -53.65% | -641.24% | -0.57% | -0.16% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 407.92 | 78.33 | 21.29 | 11.17 | 0.00 |
| Payables Turnover | 6.72 | 4.09 | 7.15 | 38.31 | 0.00 |
| Inventory Turnover | 25.74 | 22.96 | 12.52 | 41.95 | 0.00 |
| Fixed Asset Turnover | 2.01 | 1.74 | 1.22 | 1.25 | 0.00 |
| Asset Turnover | 0.82 | 0.77 | 0.49 | 0.40 | 0.00 |
| Working Capital Turnover Ratio | -2.67 | -2.84 | -3.84 | 12.37 | 0.00 |
| Cash Conversion Cycle | -39.25 | -68.64 | -4.73 | 31.84 | 0.00 |
| Days of Sales Outstanding | 0.89 | 4.66 | 17.15 | 32.66 | 0.00 |
| Days of Inventory Outstanding | 14.18 | 15.90 | 29.14 | 8.70 | 0.00 |
| Days of Payables Outstanding | 54.33 | 89.20 | 51.02 | 9.53 | 0.00 |
| Operating Cycle | 15.07 | 20.56 | 46.29 | 41.37 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.80 | -1427.26 | -23.79 | -9.04 | -0.13 |
| Free Cash Flow Per Share | -1.85 | -1570.60 | -25.38 | -20.77 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | -42.04 | -9.96 | -15.04 | -0.77 | 0.00 |
| Capital Expenditure Coverage Ratio | -42.04 | -9.96 | -15.04 | -0.77 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.61 | -0.21 | -0.11 | -0.15 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.60 | -0.23 | -0.27 | -0.40 | 0.00 |
| Free Cash Flow Yield | -38.53% | -182.26% | -0.33% | -0.27% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.84 | -0.16 | -174.57 | -644.21 | -59830.24 |
| Price-to-Sales (P/S) Ratio | 1.60 | 0.14 | 87.19 | 336.38 | 0.00 |
| Price-to-Book (P/B) Ratio | 17.02 | -2.93 | -166.97 | -986.64 | 15032.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.60 | -0.55 | -302.45 | -369.53 | -59830.24 |
| Price-to-Operating Cash Flow Ratio | -2.66 | -0.60 | -322.57 | -849.03 | -59830.24 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.00 | -0.65 | -0.07 | 0.00 |
| Enterprise Value Multiple | -4.47 | -1.90 | -302.97 | -882.00 | 0.00 |
| Enterprise Value | 42.43M | 20.55M | 880.65M | 862.12M | 330.24M |
| EV to EBITDA | -4.47 | -1.90 | -302.97 | -882.00 | 0.00 |
| EV to Sales | 2.56 | 1.23 | 89.54 | 338.20 | 0.00 |
| EV to Free Cash Flow | -4.14 | -4.89 | -310.62 | -371.53 | -59826.26 |
| EV to Operating Cash Flow | -4.24 | -5.38 | -331.28 | -853.61 | -59826.26 |
| Tangible Book Value Per Share | -1.46 | -4276.76 | -138.55 | -24.34 | 0.51 |
| Shareholders’ Equity Per Share | 0.28 | -294.46 | -45.97 | -7.78 | 0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.01 | -0.06 | 0.00 |
| Revenue Per Share | 2.99 | 6229.13 | 88.03 | 22.82 | 0.00 |
| Net Income Per Share | -2.57 | -5525.92 | -43.96 | -11.91 | -0.13 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 1.06 | 1.00 |
| Interest Burden | 1.28 | 1.21 | 1.41 | 1.18 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.69 | 0.57 | 0.56 | 0.70 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 |
| Income Quality | 0.70 | 0.26 | 0.54 | 0.76 | 1.00 |
Currency in USD
